Skip to main content
Premium Trial:

Request an Annual Quote

Undisclosed Biotech to Use Pharsight Knowledgebase Server

NEW YORK, May 29 (GenomeWeb News) - Pharsight said last week that "a leading human therapeutics company in the biotechnology industry" has licensed the Pharsight Knowledgebase Server, a data repository for managing modeling and simulation data.

 

The new customer will also upgrade its existing licenses of WinNonlin, Pharsight's tool for non-compartmental analysis of pharmacokinetic and pharmacodynamic data, the company said.

 

Pharsight said that it has now signed 17 PKS agreements with pharmaceutical and biotechnology firms.

 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.